Relationship between retinal vessel diameters and retinopathy in the Inter99 Eye Study by Drobnjak, Dragana et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Relationship between retinal vessel diameters and retinopathy in the Inter99 Eye Study
Drobnjak, Dragana; Munch, Inger Christine; Glümer, Charlotte; Færch, Kristine; Kessel, Line;
Larsen, Michael; Veiby, Nina C B B
Published in:
Journal of Clinical and Translational Endocrinology
DOI:
10.1016/j.jcte.2017.03.002
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC-ND
Citation for published version (APA):
Drobnjak, D., Munch, I. C., Glümer, C., Færch, K., Kessel, L., Larsen, M., & Veiby, N. C. B. B. (2017).
Relationship between retinal vessel diameters and retinopathy in the Inter99 Eye Study. Journal of Clinical and
Translational Endocrinology, 8, 22-28. https://doi.org/10.1016/j.jcte.2017.03.002
Download date: 03. Feb. 2020
Journal of Clinical & Translational Endocrinology 8 (2017) 22–28Contents lists available at ScienceDirect
Journal of Clinical & Translational Endocrinology
journal homepage: www.elsevier .com/locate / jc teRelationship between retinal vessel diameters and retinopathy in the
Inter99 Eye Studyhttp://dx.doi.org/10.1016/j.jcte.2017.03.002
2214-6237/ 2017 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: CRVE, central retinal vein equivalent diameter; CRAE, central
retinal artery equivalent diameter; ETDRS, early treatment diabetic retinopathy
study; HbA1c, glycated hemoglobin; NPDR, non-proliferative diabetic retinopathy.
⇑ Corresponding author.
E-mail addresses: gagid100@hotmail.com (D. Drobnjak), icm@dadlnet.dk
(I.C. Munch), FS0H@SUF.KK.dk (C. Glümer), kristine.faerch@regionh.dk (K. Færch),
line.kessel@dadlnet.dk (L. Kessel), MICLAR01@regionh.dk (M. Larsen), ninat@
dadlnet.dk (N.C.B.B. Veiby).
Downloaded for Anonymous User (n/a) at BS - University of Copenhagen from ClinicalKey.com by Elsevier on April 04, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.Dragana Drobnjak a,⇑, Inger Christine Munch b,c, Charlotte Glümer d, Kristine Færch e, Line Kessel b,f,
Michael Larsen b,f, Nina C.B.B. Veiby a
aCenter of Eye Research, Department of Ophthalmology, Oslo University Hospital and University of Oslo, Oslo, Norway
b Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
cDepartment of Ophthalmology, Zealand University Hospital, Roskilde, Denmark
dResearch Center for Prevention and Health, Glostrup, Denmark
e Steno Diabetes Center, Gentofte, Denmark
fDepartment of Ophthalmology, Rigshospitalet – Glostrup, Copenhagen, Denmark
a r t i c l e i n f o a b s t r a c tArticle history:
Received 28 December 2016
Received in revised form 14 March 2017
Accepted 17 March 2017
Keywords:
Retinal vessel diameter
Fundus photographs
Retinopathy
Inter99
Cohort study
Diabetic retinopathy screeningPurpose: To examine the association between retinal vessel diameters and retinopathy in participants
with and without type 2 diabetes in a Danish population-based cohort.
Methods: The study included 878 persons aged 30 to 60 years from the Inter99 Eye Study. Retinopathy
was defined as a presence of one or more retinal hemorrhages or one or more microaneurysms. Vessel
diameters were expressed as central retinal artery equivalent diameter (CRAE) and central retinal vein
equivalent diameter (CRVE). Multiple linear regression analyses were performed.
Results: Among participants with diabetes, CRAE was 6.3 mm (CI 95%: 1.0 to 11.6, p = 0.020) wider and
CRVE was 7.9 mm (CI 95%: 0.7 to 15.2, p = 0.030) wider in those with retinopathy compared to those with-
out retinopathy, after adjusting for age, gender, HbA1c, blood pressure, smoking, serum total and HDL
cholesterol. In all participants, CRAE increased with presence of retinopathy (p = 0.005) and with smoking
(p = 0.001), and CRAE decreased with hypertension (p < 0.001), high HDL cholesterol (p = 0.016) and age
(p < 0.001). Central retinal vein equivalent diameter increased with presence of retinopathy (p = 0.022)
and with smoking (p < 0.001), and decreased with higher HDL cholesterol (p < 0.001) and age
(p = 0.015). Female gender was associated with wider CRVE (p = 0.029).
Conclusions: Wider retinal vessel diameters were associated with the presence of retinopathy in partic-
ipants with diabetes, but not in participants without diabetes. The associations between retinal vessel
diameters and known retinopathy risk factors were confirmed. These results suggest that information
obtained by non-invasive imaging of the interior of the eye can contribute to a better understanding of
systemic disease processes.
 2017 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Diabetes is now regarded as an epidemic with the population of
patients expected to rise to 380 million in the world by 2025 [1].
The presence of either intraretinal hemorrhages or the localizedoutpouchings of capillaries known as microaneurysms defines
the lower threshold of retinopathy. Retinopathy is estimated to
affect between 1% and 15% of people without diabetes mellitus
[2]. There are few epidemiologic data describing the incidence of
retinopathy and associated risk factors in non-diabetic populations
[3,4]. Previous studies have shown a relationship between wider
retinal vessel diameter and retinopathy development in a diabetic
population [5–7]. The presence of retinopathy increases the risk of
coronary heart disease (CHD) mortality in people with and without
diabetes [8].
The retinal blood vessels are accessible to direct non-invasive
visualization providing the opportunity to investigate microvascu-
lar changes before reaching a stage of proliferative retinopathy.
D. Drobnjak et al. / Journal of Clinical & Translational Endocrinology 8 (2017) 22–28 23The development of semi-automatic retinal vessel measurement
techniques, in digital fundus photographs, has made it possible
to analyze even modest retinal vessel narrowing and dilatation
which simple ophthalmoscopy has been unable to detect. This
was first published in the Atherosclerosis Risk in Communities
Study 20 years ago [9]. Improvements in digital retinal photogra-
phy and imaging technology can now allow objective documenta-
tion of retinal vascular characteristics [10].
The aim of this study was twofold: 1) to examine the associa-
tions between retinal vessel diameters and retinopathy in partici-
pants with and without diabetes type 2, and 2) to assess the
associations between retinal vessel diameters and known
retinopathy risk factors in a Danish population-based cohort.Subjects, materials and methods
Study population
The study population of the Inter99 study comprised an age-
and sex-stratified sample of 13.016 participants residing in 11 sub-
urban municipalities of the south-western part of Copenhagen
County. The study sample was randomized from the Danish Civil
Registration System that comprises all participants permanently
residing in Denmark. A total of 6784 participants aged 30–60 years
underwent the screening-program at the Research Center for
Prevention and Health at Copenhagen University Hospital in
Glostrup, Denmark.
A subgroup of 1437 participants was invited for the Inter99 Eye
Study and 970 (67.5%) participated in the eye examination. The
subgroup was chosen based on the following criteria: 1) an age-
and sex-stratified control group polled to match the background
population (n = 500), and 2) participants with known or screen-
detected diabetes, and participants with a high risk of ischemic
heart disease (n = 470). All study participants with missing data
or ungradable images were excluded (n = 92). Thus, a total of 878
participants were included in the present study.
The prevalence and associations of retinopathy in participants
without diabetes, participants with type 2 diabetes, and partici-
pants with impaired glucose regulation in Inter99 Eye Study pop-
ulation was reported elsewhere [4,13,14].Study procedures
All participants showed up for a clinical examination after an
overnight fast. Blood pressure, height, weight, waist and hip cir-
cumference, total cholesterol, HDL-cholesterol, triglyceride and
plasma glucose were measured and a standard 75 g oral glucose
tolerance test was performed. Questionnaires including informa-
tion on lifestyle, chronic diseases and family history of chronic dis-
eases were collected in all participants. A detailed description of
Inter99 Study has been published previously [12].
Fundus photographs were captured using 60 digital grey-scale
(red-free) fundus photographs and 60 colour fundus photographs
on transparency film centred on the macula and optic disc. A green
filter for red-free photographs was used to enhance the sharpness
and contrast of the blood vessels. Retinal vessel diameters were
measured according to international standards (Vessel Measure-
ment System, IVAN protocol, version 2, University of Wisconsin),
using semi-automatic software for vessel measurement developed
in Denmark [15].
Absolute distances were calculated assuming a uniform vertical
optic disc diameter of 1800 mm. A standard grid containing three
concentric circles was placed centred at the papilla on the images.
The grader then identified all the arteries and veins between the
outer two circles, using red and blue lines for arteries and veins,Downloaded for Anonymous User (n/a) at BS - University of Copen
For personal use only. No other uses without permission. Crespectively, to delineate the borders of the blood vessels, which
were defined, in this context, as the edges of the blood column
the vessel wall being translucent. The program identified the six
largest arteries and the six largest veins and calculated the central
retinal artery equivalent (CRAE) and the central retinal vein equiv-
alent (CRVE) according to the formulas described by Knudtson
et al. [16].
We tested the IVAN software against our Danish custom-
developed semi-automatic software in 20 red free fundus pho-
tographs. We found intraclass correlation coefficients (ICC) of 0.8
(95% CI: 0.5 to 0.9) for CRAE and 0.9 (95% CI: 0.8 to 0.9) for CRVE
and there were no significant differences between measurements
of CRAE (p = 0.448) and CRVE (p = 0.828). The inter grader reliabil-
ity between 2 independent masked graders using our Danish pro-
gram was 0.9 (ICC) for arteries and 0.8 (ICC) for veins, measured on
45 fundus photographs. The mean difference in vessel diameter
among the two graders was 3.9 mm (0.024%) for arteries and
6.2 mm (0.025%) for veins.
The photographs were graded for retinal lesions and classified
according to the retinopathy severity scale from the early treat-
ment diabetic retinopathy study (ETDRS) [17]. The maximum
grade in any of the seven standard photographic fields in any of
a subjects two eyes determined the retinopathy level [4].Definitions
We used the glycaemia thresholds from the World Health Orga-
nization (WHO) 1999 criteria [11]. Participants who reported being
unaware of having diabetes and were later found to have a fasting
plasma glucose concentration 7.0 mmol/L or a 2-h plasma glu-
cose concentration 11.1 mmol/L were diagnosed as having
screen-detected diabetes. Subjects with self-reported diabetes
were classified as having known diabetes. Hypertension was
defined as blood pressure over 140/90 mmHg.
Retinopathy was present, by definition, in participants where
one or both eyes were classified as ETDRS level 15 or higher (reti-
nal hemorrhages present without any definite micro aneurysms or
other lesions) [4]. Mild retinopathy or worse was classified as
ETDRS level 35 (More than just micro aneurysms but less than
severe non- proliferative Diabetic Retinopathy (NPDR)).Statistical analyses
Retinal vessel variables were found to be normally distributed.
These variables are therefore presented as means with standard
deviations.
Since we had very few cases with moderate to severe retinopa-
thy it was appropriate to include retinopathy as a dichotomous
variable (15).
First, we compared retinal vessel variables between participants
with and without retinopathy. For this analysis we used a two-
tailed, unpaired Student’s samples t-test.
In the second analysis, we studied associations between retinal
vessel diameters as dependent variables (CRAE and CRVE) and
retinopathy as independent variable using multiple linear regres-
sion analyses. The assumptions underlying such analysis were
checked, and found to be adequately met (linearity, normal distri-
bution of residuals, and acceptable collinearity using the VIF
statistic).
Linear regression analysis was also used to identify possible
interactions between selected pairs of independent variables.
There was no significant interaction between retinopathy and dia-
betes status on the association with CRAE and CRVE. However,
stratified analyses were performed because of support in biological
theories.hagen from ClinicalKey.com by Elsevier on April 04, 2018.
opyright ©2018. Elsevier Inc. All rights reserved.
24 D. Drobnjak et al. / Journal of Clinical & Translational Endocrinology 8 (2017) 22–28For additional adjustments we included cardiovascular risk fac-
tors (age, gender, HbA1c concentration, systolic blood pressure,
smoking, serum total and HDL cholesterol) which previously have
been shown to be associated with retinal vessel diameters, and
have been implicated in the pathogenesis of diabetes (Table 2).
Associations between retinal vessel diameters (CRAE, CRVE) and
known retinopathy risk factors (age, gender, total cholesterol, HDL
cholesterol, LDL cholesterol, triglycerides, hypertension, smoking,
body mass index (BMI), diabetes mellitus and glucose regulation),
were tested by multiple linear regression analyses with backward
variable selection. Step 1 was to include all the variables that were
significant in unadjusted analyses (age, gender, hypertension, total
cholesterol, HDL cholesterol, smoking, diabetes, HbA1c, fasting p-
glucose, 2-h OGTT p-glucose and BMI). Step 2 was to remove the
variable with the highest P value, and to run the model once more.
Step 3 was to repeat step 2 until all the remaining variables were
significant (Table 3). Statistically, hypertension and antihyperten-
sive treatment were treated as one.
There were no significant interactions between the two ascer-
tainment groups (one control group polled to match the back-
ground population and one group with persons with known or
newly diagnosed diabetes mellitus and persons with a high risk
of ischemic heart disease) and the tested variables, meaning that
the associations between retinopathy and risk factors (age, gender,
fasting p-glucose and smoking) did not differ between the two
ascertainment groups. Therefore, we presented the results of a
combined analysis (878 persons) only.
A paired, two-tailed, Student’s T-test was used when comparing
IVAN software with Danish custom-developed semi-automatic
software.Table 1
Clinical characteristics of the Inter99 Eye Study population.
Total
number
(n = 878)
cAll participants Partici
No retinopathy
(n = 779), 89%
bAny
retinopathy
(n = 99), 11%
p
value
No ret
(n = 62
CRAE (mm) 878 163.0 (16.0) 166.0 (15.0) 0.101 164.0
CRVE (mm) 878 250.4 (21.0) 256.0 (22.3) 0.017 250.4
SBP (mmHg) 878 132.4 (17.3) 138.4 (19.1) 0.001 130.5
DBP (mmHg) 878 83.8 (11.2) 85.5 (10.8) 0.159 82.7 (
Age (year) 878 47.5 (7.6) 49.8 (7.2) 0.004 47 (7.
Gender (male/
female), %
878 48%/52% 56%/44% 0.098 47% /5
BMI (kg/m2)a 878 26.0
(17.8–53.4)
28.4
(17.5–34.8)
0.010 26.1
(17.7–
Total cholesterol
(mmol/L)
877 5.7 (1.2) 5.8 (1.1) 0.585 5.8 (1
HDL cholesterol
(mmol/L)
878 1.3 (0.3) 1.4 (0.4) 0.326 1.4 (0
LDL cholesterol
(mmol/L)
430 3.6 (1.0) 3.7 (1.0) 0.531 3.6 (1
Fasting p-
glucose
(mmol/L)a
878 5.6 (3.0–20.9) 6.0 (4.8–19.7) <0.001 5.5 (3
2-h OGTT p-
glucose
(mmol/L)a
858 6.8 (2.3–30.6) 7.9 (3.9–25.9) 0.033 6.2 (2
HbA1c (%) 877 6.0 (0.8) 6.4 (1.5) 0.006 5.8 (0
Smoking (pack
years)a
878 4.5 (0.0–112.5) 7.5 (0.0–90.0) 0.080 3.6 (0
Values are given as means (SD) unless otherwise stated.
a Values are given as medians (interquartile range).
b Grading for retinopathy was available for 878 participants. Ninety-two participants
c The inclusion of a random sample of the background population made it possible to e
to think that the associations we found differed between the 2 ascertainment groups a
insignificant.
Downloaded for Anonymous User (n/a) at BS - University of Co
For personal use only. No other uses without permissioThe statistical software package SPSS version 18 was used to
perform the statistical analysis. A significance level of 0.05 was
used throughout.Results
This study included 878 participants, aged 30–60 years. Among
the participants with diabetes (n = 199), 42 (21%) had retinopathy,
whereas 57 (8%) had retinopathy among participants without dia-
betes (n = 679) (Fig. 1). In this study 3 participants had type 1 dia-
betes, and the 196 had type 2 diabetes.
Clinical characteristics of the study population are shown in
Table 1. Participants with diabetes with retinopathy had signifi-
cantly larger CRAE (p = 0.035), significantly larger CRVE
(p = 0.039) and significantly higher fasting plasma glucose
(p = 0.017) compared to the participants with diabetes without
retinopathy. Participants without diabetes with retinopathy had
significantly higher BMI (p = 0.022) compared to participants with-
out diabetes without retinopathy. The prevalence of retinopathy in
non-diabetic participants without hypertension was 7.5%, and in
participants with hypertension 10.5%, as reported previously [4].
There were no significant interactions between the presence of
retinopathy and the presence of diabetes on the effect of CRAE
(p = 0.225) and CRVE (p = 0.350).
In the crude analysis there was statistical significant difference
in CRAE between non-diabetic participants without and with
hypertension (p < 0.001). There was no statistical significant differ-
ence in CRVE between non-diabetic participants without and with
hypertension (p = 0.921).pants without diabetes Participants with diabetes
inopathy
2), 92%
bAny
retinopathy
(n = 57), 8%
p
value
No retinopathy
(n = 157), 79%
bAny
retinopathy
(n = 42), 21%
p
value
(15.6) 165.0 (13.4) 0.338 161.0 (16.8) 167.0 (15.6) 0.035
(20.6) 254.0 (24.0) 0.255 250,3 (21.4) 258.0 (20.3) 0.039
(16.3) 134.0 (20.2) 0.195 141.3 (18.5) 143.7 (16.7) 0.445
11.0) 83.6 (11.0) 0.565 88.4 (11.3) 87.5 (10.2) 0.837
6) 49 (7.5) 0.066 51 (7.2) 51.3 (6.7) 0.641
3% 46%/54% 0.847 56%/44% 72%/29% 0.072
53.4)
27.3
(17.5–34.8)
0.022 29.6
(20.1–46.2)
29.4
(21.1–34.0)
0.210
.2) 5.7 (1.5) 0.909 5.9 (1.0) 6.0 (1.1) 0.706
.4) 1.4 (0.4) 0.467 1.2 (0.3) 1.3 (0.4) 0.214
.0) 3.8 (1.1) 0.505 3.6 (1.1) 3.6 (1.0) 0.986
.0–6.9) 5.6 (4.8–6.8) 0.103 7.0 (3.9–20.9) 7.4 (5.0–19.7) 0.017
.3–11.0) 6.2 (3.9–10.9) 0.676 12.4 (3.9–30.6) 12.4 (4.2–25.9) 0.713
.4) 5.8 (0.4) 0.878 6.7 (1.4) 7.2 (1.9) 0.128
.0–76.0) 4.6 (0.0–5.5) 0.215 7.6 (0.0–112.5) 14.0 (0.0–90.0) 0.677
were excluded because fundus photographs were ungradable.
stimate the prevalence of retinopathy in the general population. We have no reason
s test for interaction between associated variables and ascertainment group were
penhagen from ClinicalKey.com by Elsevier on April 04, 2018.
n. Copyright ©2018. Elsevier Inc. All rights reserved.
Table 3
Association between retinal vessel diameters (CRAE and CRVE) and individual risk
factors for retinopathy onset, after multiple linear regression analyses.
Total number
N = 878
Central retinal artery equivalent diameter (CRAE), mm
Coefficient (mm) 95% confidence interval P Value
Hypertension
(yes/not)
8.5 10.6 to 6.4 <0.001
Age (mm/1 year) 0.3 0.4 to 0.1 <0.001
Smoking (yes/no) 0.1 0.4 to 0.1 0.001
HDL (mmol/L) 3.0 5.5 to 0.5 0.016
Any Retinopathy 4.5 1.4 to 7.6 0.005
Central retinal vein equivalent diameter (CRVE), mm
Smoking (yes/no) 0.2 0.1 to 0.3 <0.001
HDL (mmol/L) 6.0 10.4 to 3.5 <0.001
Age (mm/1 year) 0.2 0.4 to 0.04 0.015
Gender (female) 3.1 0.3 to 6.0 0.029
Any retinopathy 4.7 0.7 to 9.1 0.022
The model initially included the variables: retinopathy, age, gender, total choles-
terol, HDL cholesterol, LDL cholesterol, triglycerides, hypertension, smoking, body
mass index, diabetes mellitus and glucose regulation.
Table 2
Associations between retinal vessel diameters (CRAE and CRVE) and retinopathy.
All participants, any retinopathy
Total number of cases (n = 99)
Participants without diabetes, any retinopathy
Total number of cases (n = 57)
Participants with diabetes, any retinopathy
Total number of cases (n = 42)
Coefficient
(mm)
95% confidence
interval
P
Value
Coefficient
(mm)
95% confidence
interval
P
Value
Coefficient
(mm)
95% confidence
interval
P
Value
CRAE (mm) 4.2 1.1 to 7.2 0.007 2.8 1.1 to 6.7 0.159 6.3 1.0 to 11.6 0.020
CRVE (mm) 4.9 0.7 to 9.2 0.021 2.4 3.0 to 8.0 0.382 7.9 0.7 to 15.2 0.030
Retinal vessel diameters (CRAE and CRVE) were used as dependent variables and retinopathy as independent variable in multiple linear regression analyses.
Adjusted for age, gender, HbA1c concentration, systolic blood pressure, smoking, serum total and HDL cholesterol.
D. Drobnjak et al. / Journal of Clinical & Translational Endocrinology 8 (2017) 22–28 25When evaluating the association between glycemic indicators
(fasting plasma glucose, 2-h plasma glucose and HbA1c) with CRAE
and CRVE in participants with diabetes, the association between
HbA1c and CRAE was statistically significant (p = 0.005; 95% CI:
0.8 to 4.8), as was the association between HbA1c and CRVE
(p = 0.038; 95% CI: 0.1 to 5.6).
Associations between vessel diameters (CRAE and CRVE) and
retinopathy after multiple linear regression analyses, adjusted for
age, gender, HbA1c, systolic blood pressure, smoking, serum total
and HDL cholesterol, are shown in Table 2.Central retinal artery equivalent (CRAE)
All participants
Multiple linear regression analyses showed that CRAE was
4.2 mm (p = 0.007) wider in participants with retinopathy com-
pared to participants without retinopathy.Participants without diabetes
CRAE was wider in subjects with retinopathy compared to sub-
jects without retinopathy but not significantly.Participants with diabetes
CRAE was 6.3 mm (p = 0.020) wider in participants with
retinopathy compared to participants without retinopathy.Downloaded for Anonymous User (n/a) at BS - University of Copen
For personal use only. No other uses without permission. CCentral retinal vein equivalent (CRVE)
All participants
Multiple linear regression analyses showed that CRVE was
4.9 mm (p = 0.021) wider in participants with retinopathy com-
pared to participants without retinopathy.
Participants without diabetes
CRVE was wider in subjects with retinopathy compared to sub-
jects without retinopathy but not significantly.
Participants with diabetes
CRVE was 7.9 mm (p = 0.030) wider in participants with
retinopathy compared to participants without retinopathy.
Associations between retinal vessel diameters (CRAE and CRVE)
and known retinopathy risk factors (age, gender, total cholesterol,
HDL cholesterol, LDL cholesterol, triglycerides, hypertension,
smoking, body mass index, diabetes mellitus and glucose regula-
tion) were tested by multiple linear regression analyses with back-
ward variable selection. The results are presented in Table 3.
Central retinal artery equivalent diameter increased with retinopa-
thy (p = 0.005) and with smoking (0.001), and CRAE decreased with
hypertension (p < 0.001), high HDL cholesterol (p = 0.016) and age
(p < 0.001). Central retinal vein equivalent diameter increased with
retinopathy (p = 0.022) and with smoking (p < 0.001), and CRVE
decreased with high HDL cholesterol (p < 0.001) and age
(p = 0.015). Female gender was associated with wider CRVE
(p = 0.029).
Discussion
In this large population-based, cross-sectional study of adult
Danes aged 30–60 years we have demonstrated a significant asso-
ciation between wider CRAE and wider CRVE and retinopathy in
participants with diabetes. We found no significant association
between retinopathy and retinal vessel diameters in participants
without diabetes. Furthermore, CRAE increased with smoking,
and CRAE decreased with hypertension, high HDL cholesterol and
age. Central retinal vein equivalent diameter increased with smok-
ing, and CRVE decreased with high HDL cholesterol and age.
Female gender was associated with wider CRVE.
We defined retinopathy at the lowest possible threshold,
namely as the presence of one or more retinal hemorrhages or
one or more microaneurysms. This threshold was chosen as the
presence of higher grades of retinopathy is rare among subjects
without diabetes [4]. Also a threshold of having any hemorrhages
or microaneurysm is more easy to administer in a clinical setting.
We found an association between wider CRAE and retinopathy
in participants with diabetes. There may be two possible explana-
tions for this. First, dilated arterioles may be seen as a breakdown
of autoregulation in the eyes of participants with diabetes and thathagen from ClinicalKey.com by Elsevier on April 04, 2018.
opyright ©2018. Elsevier Inc. All rights reserved.
Fig. 1. Flow chart of the Inter99 Eye Study population.
26 D. Drobnjak et al. / Journal of Clinical & Translational Endocrinology 8 (2017) 22–28would render them susceptible to incident retinopathy [18]. Sec-
ond, arterioles could be wider because of peripheral ischemia
and the autoregulation is intact which means that they will dilate
to increase blood flow. In a few previous studies retinal artery
diameter was not associated with development of more severe
retinopathy stages [4–7,12,19–24]. On the other hand, in 2004
Klein R. et al. concluded that larger artery calibre independently
of retinopathy severity level is related to the progression of dia-
betic retinopathy [6].
We found an association between wider CRVE and retinopathy
in persons with diabetes, which can be explained by the hypothesis
that vein dilatation in eyes can be a result of lactic acidosis associ-
ated with retinal hypoxia [25]. Others have found that larger vein
diameter is an independent indicator of progression to either pro-
liferative diabetic retinopathy or to non-proliferative diabetic
retinopathy with high-risk characteristics [7].
Retinopathy and cardiovascular disease share many associated
risk factors [8]. In our cohort we confirmed an association
between retinopathy and CRAE widening and CRVE widening
[26] as well as between smoking and CRAE widening and CRVEDownloaded for Anonymous User (n/a) at BS - University of Co
For personal use only. No other uses without permissiowidening [27]. Smoking-induced increase in nitric oxide produc-
tion, potassium channel activation [28] and possible tissue degen-
eration might explain retinal arterial and vein dilatation. Higher
serum HDL cholesterol and aging were independently associated
with CRAE narrowing and CRVE narrowing in our study which
is consistent with findings from previous studies [29,30]. High
levels of serum cholesterol are associated with an increased risk
of cardiovascular diseases [31], diabetic retinopathy [32], but
not with retinopathy itself [33]. Therefore, the role of hyperlipi-
demia in retinopathy is not entirely clear. Thus, it is suggested
that more may be learned from a closer inspection of those
mechanisms.
Female gender was associated with wider CRVE in our study.
Mean age for females in our study was 47 years, meaning that they
were moving toward menopause. The role of gender as a contribut-
ing factor in retinopathy has long been debated. It appears that any
treatment of diabetic retinopathy using sex hormones, or their
blockers, may not be a ‘‘one size fits all” treatment, but may vary
according to the life stage, level of retinopathy and the gender of
an individual [34].penhagen from ClinicalKey.com by Elsevier on April 04, 2018.
n. Copyright ©2018. Elsevier Inc. All rights reserved.
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ing in our study. In the Anglo-Scandinavian Cardiac Outcomes Trial
involving 712 hypertensive individuals, despite similar blood pres-
sure levels, persons randomized to receive the calcium channel
blocker amlodipine besylate had a smaller arteriole length to diam-
eter ratio, a measure of retinal arteriole narrowing, than those ran-
domized to receive the -blocker atenolol [35].
Maybe lack of adjustment for antihypertensive treatment can
explain associations in our study. Population-based studies which
used retinal photographs to define signs of retinopathy found signs
of retinopathy in 2–14% of non-diabetic population aged above
40 years [18,36–38] in line with the prevalence we found in our
population [4]. To the best of our knowledge, there are no pub-
lished histology studies of non-diabetic retinopathy. Thus, we do
not know if non-diabetic retinopathy is a separate entity at the
ultrastructural level.
Association of change in CRAE and CRVE with the incidence of
diabetic retinopathy raises the question of whether measurement
of CRAE and CRVE will detect even earlier clinically meaningful
stages of diabetic retinopathy before the onset of microaneurysms
and blot hemorrhages [39] . Since changes in retinal vessel diame-
ter reflect a range of subclinical pathophysiologic responses to
endothelial dysfunction, one can consider findings from our cohort
as a contribution to understanding the etiology of retinal changes.
Ophthalmologists may in the future be able to use desktop soft-
ware, linked to a fundus camera, to measure retinal vessel diame-
ter in the clinic, and then use the additional information to
determine which patients will develop retinopathy and therefore
be able to set in treatment to prevent it [10].
Strengths of the present study include a population-based, large
sample of participants, a computer-assisted measurement of reti-
nal vessel diameters from clear digital fundus images, and a stan-
dardized protocol.
There are a few noteworthy limitations. First, unknown sources
of variability in vessel measurements cannot be excluded despite
high reproducibility of measurements. Second, the fundus photog-
raphy was not electrocardiograph synchronized, therefore poten-
tial variations in vessel diameters may have been introduced
because of physiologic variations in cardiac cycle may influence
the vessel calibers [25]. Third, dose-response relationship (worse
retinopathy-thicker vessel) was impossible to test due to only
few cases of moderate retinopathy. Fourth, the cross-sectional
design is an important limitation that needs to be mentioned.
Furthermore, the ICC results in our study indicate that retinal
vessel diameters calculated by the Danish custom-developed
semi-automatic software are comparable with retinal vessel diam-
eters calculated by the IVAN software and have a high inter-rate
reliability. The lengths of 95% confidence intervals for the calcu-
lated ICC‘s are relatively short. This indicates that 20 pictures are
significant for calculating these ICC’s. Thus, the Danish custom
developed software provides reliable research tool for objective
assessment of structural vascular changes.
In conclusion, we have demonstrated that wider retinal artery
and vein diameters were independently associated with the pres-
ence of retinopathy in participants with diabetes but not in par-
ticipants without diabetes. The associations between retinal
vessel diameters and known risk factors for retinopathy were
confirmed. The possible clinical utility of our findings awaits
future research addressing whether a single fundus photograph
can be used in the early evaluation of an individual patient’s
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